InnoCare Pharma Limited (9969.HK)

HKD 6.1

(0.16%)

Operating Expenses Summary of InnoCare Pharma Limited

InnoCare Pharma Limited's latest annual operating expenses in 2023 was 1.26 Billion CNY , up 3.85% from previous year.
InnoCare Pharma Limited's latest quarterly operating expenses in 2024 Q1 was 287.19 Million CNY , down -6.8% from previous quarter.
InnoCare Pharma Limited reported a annual operating expenses of 1.21 Billion CNY in annual operating expenses 2022, up 6.32% from previous year.
InnoCare Pharma Limited reported a annual operating expenses of 1.14 Billion CNY in annual operating expenses 2021, up 130.08% from previous year.
InnoCare Pharma Limited reported a quarterly operating expenses of 354.64 Million CNY for 2024 Q2, up 18.49% from previous quarter.
InnoCare Pharma Limited reported a quarterly operating expenses of 1.25 Billion CNY for 2023 FY, up 3.85% from previous quarter.

Annual Operating Expenses Chart of InnoCare Pharma Limited (2023 - 2017)

Historical Annual Operating Expenses of InnoCare Pharma Limited (2023 - 2017)

Year	Operating Expenses	Operating Expenses Growth
2023	1.26 Billion CNY	3.85%
2022	1.21 Billion CNY	6.32%
2021	1.14 Billion CNY	130.08%
2020	495.91 Million CNY	96.89%
2019	251.87 Million CNY	67.62%
2018	150.26 Million CNY	123.86%
2017	67.12 Million CNY	0.0%

Year	Operating Expenses	Operating Expenses Growth
2024 Q1	287.19 Million CNY	-6.8%
2024 Q2	354.64 Million CNY	18.49%
2023 FY	1.25 Billion CNY	3.85%
2023 Q4	308.14 Million CNY	-10.49%
2023 Q3	344.23 Million CNY	-2.34%
2023 Q1	254.96 Million CNY	-21.08%
2023 Q2	352.47 Million CNY	38.25%
2022 Q4	323.05 Million CNY	-15.09%
2022 Q3	380.47 Million CNY	-14.98%
2022 Q2	447.51 Million CNY	87.16%
2022 Q1	239.1 Million CNY	3.45%
2022 FY	1.21 Billion CNY	6.32%
2021 Q1	182.05 Million CNY	226.07%
2021 Q3	534.81 Million CNY	193.76%
2021 Q4	231.12 Million CNY	-56.78%
2021 Q2	182.05 Million CNY	0.0%
2021 FY	1.14 Billion CNY	130.08%
2020 FY	495.91 Million CNY	96.89%
2020 Q1	189.49 Million CNY	114.74%
2020 Q3	55.83 Million CNY	-70.54%
2020 Q2	189.49 Million CNY	0.0%
2020 Q4	55.83 Million CNY	0.0%
2019 Q3	68.21 Million CNY	-61.68%
2019 Q2	178.04 Million CNY	0.0%
2019 Q1	178.04 Million CNY	258.48%
2019 FY	251.87 Million CNY	67.62%
2019 Q4	88.24 Million CNY	29.35%
2018 Q3	182.83 Million CNY	31.71%
2018 Q4	49.66 Million CNY	-72.84%
2018 Q1	138.81 Million CNY	0.0%
2018 Q2	138.81 Million CNY	0.0%
2018 FY	150.26 Million CNY	123.86%
2017 FY	67.12 Million CNY	0.0%

Peer Operating Expenses Comparison of InnoCare Pharma Limited

Name	Operating Expenses	Operating Expenses Difference
Uni-Bio Science Group Limited	325.05 Million HKD	-288.019%
CK Life Sciences Int'l., (Holdings) Inc.	739.25 Million HKD	-70.612%